Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

NCT00332917 is registered in ClinicalTrials.gov with Solvay Pharmaceuticals as lead sponsor.

NCT NCT00332917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00332917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients
Lead sponsor
Solvay Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
July 31, 2008
Enrollment
224 (actual)
Sites
130

Conditions

As the registry lists them; a condition with its own page is linked.

early stage parkinson's disease